Erasca Stock

erasca.comHealthcareFounded: 2018Funding to Date: $64MM

Erasca is a biotechnology company committed to solving oncology’s hardest problems.

Register for Details

For more details on financing and valuation for Erasca, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Erasca.

Register Today

Team

Management Team

Gary Yeung
Chief Business Officer
Jonathan Lim MD
Founder and Executive Chairman

Board Members

James Bristol Ph.D
Jonathan Lim MD
Pratik Multani MD
Alexander Casdin

Other companies like Erasca in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

Erasca will use the funding to drive corporate development efforts and further advance the company’s in-house drug discovery pipeline.
San Diego-based cancer treatment startup Erasca raised $200 million in a new round of funding, the company announced Monday.
Erasca, a San Diego, CA-based develper of oncology programs, completed a $200m Series B financing round co-led by Arch Venture Partners and Cormorant Asset Management